Pablo Cresta

Physician-Scientist Oncologist, researcher, statistician. ESMO Research Fellow in @VHIO

[SOLTI #cancerresearch @_SOLTI]

Se acaban de presentar, en la Sesión Plenaria de #SEOM25 los resultados de #HOPEPróstata, un estudio académico promovido por SOLTI y coordinado científicamente con el @VHIO

👉El proyecto demuestra que integrar el test genómico en cáncer de próstata metastásico es viable, ágil y equitativo en toda España, reduciendo desigualdades en el acceso a la medicina de precisión.

🎯 El Dr. Pablo Cresta ha sido el encargado de exponer estos resultados: se han analizado 208 muestras, y 3 de cada 4 pacientes ya han sido debatidos en comité molecular, con una mediana de 31 días hasta la revisión y recomendaciones terapéuticas personalizadas en el 52 % de los casos revisados.

👨‍⚕️👨‍⚕️Los investigadores principales, Dr. Joaquin Mateo y Dr. Joan Carles, destacan que HOPE Próstata identifica dianas terapéuticas relevantes y acerca nuevas opciones de tratamiento a pacientes de todo el país.

Este proyecto cuenta con el aval de SEOR, AEU y @sogug1 , y ha sido posible gracias a la colaboración de @pfizer , Alianza @Merck - @AstraZeneca , Advanced Accelerator Applications (@Novartis ), @GuardantHealth y @AstellasUS , así como al patrocinio de contenidos para pacientes por parte de @Bayer .

🗞️ Consulta la nota de prensa completa: https://t.co/O2tityxAag

#beSOLTI #SEOM2025 #Oncología #CáncerDePróstata #MedicinaDePrecisión #InvestigaciónClínica

[Joaquin Mateo @quimmateo]

@pablo_cresta @VHIO presentó hoy en #sesionplenaria #SEOM25 los resultados del estudio @_SOLTI-2102-HOPE Próstata. Mucho trabajo de mucha gente detras de estos 10 minutos, y muchos pacientes que han colaborado con sus datos, muestras y su tiempo - Gracias!

[Pablo Cresta @pablo_cresta]

Amazing experience in #ASCO24 at the Poster Session-GU Cancer. We presented our work evaluating the HRR status in mPC by NGS and the functional RAD51-IF assay.🧬💻🔬
Abstract 5024
Prostate Cancer Translational Research Team 🔝🚀
@VHIO @vallhebron @quimmateo
Thank you to all!!

[Guillermo Villacampa @G_Villacampa]

⚠️How accurate are surrogate endpoints to capture overall survival benefit in 1L trials with ICI + CT?

📢Here, we evaluate classical and novel surrogate endpoints using trial-level data from 39 RCTs @pablo_cresta @VictorNavarro32 @krys987 @rdienstmann

https://t.co/nlmxupoVmr

[Pablo Cresta @pablo_cresta]

📢I cannot recommend you more this experience. Science, cancer research, super stimulating environments, Centres of excellence, huge mentors, really nice people, and fun; all in the ESMO Research Fellowships!🔬 🧫🧬🩺
👉https://t.co/VJiHUoZjAH

[Pablo Cresta @pablo_cresta]

#ESMO22 has ended and it was a fantastic experience.
Many thanks to @MyESMO for awarding me with the #esmoresearchfellowship! Clearly, it is a landmark in my personal and professional development🚀. Thank you also to @E_de_Azambuja and @TeresaSAmaral for their support!🤗

1/4👇

[Pablo Cresta @pablo_cresta]

I want to thank my previous mentors who provided me with the tools that helped me to make this happen.🙌Monica Castro, @_lacion_, @morlaicassiopea, Adriana Perez, Alfredo Navigante y Lucas Colombo; and to my 'home' Institutes: @InstitutoRoffo and @InstitCalculo, from @UBAonline

[Pablo Cresta @pablo_cresta]

@quimmateo @myESMO @VHIO @rdienstmann Extremely happy and grateful for being part of these two amazing groups!!! 🧬🔬👨🏻‍💻
Many thanks to @quimmateo and @rdienstmann, to @VHIO, and, especially to @myESMO!! 🤗
I am really lucky! 😊

[Joaquin Mateo @quimmateo]

Our new review paper: "Clinical implications of HRR mutations in prostate cancer" lead by @pablo_cresta @VHIO for this month's special issue @ The Prostate on #prostatecancer #Genomics and #precisionmedicine #openaccess https://t.co/jMm9ROQkjH

[American Journal of Drug and Alcohol Abuse (AJDAA) @AJDAAJournal]

Practical foundations of machine learning for addiction research. Part I. Methods & techniques

@Pablo_Cresta, Carusso, @morlaicassiopea & @_LAcion_

→ https://t.co/LxhYydWXIr

#MachineLearning #AddictionResearch #ML #SubstanceUseDisorders #DataScience #AI #StatisticalMethods

[Laura Ación (@[email protected]) @_lacion_]

✨Paper quantifying the motivation behind our review by @pablo_cresta, MCarusso, @morlaicassiopea, and I soon to be published (with revisions) @AJDAAJournal

Practical foundations of ML for addiction research.
1⃣Part I: https://t.co/9DIAjLpw4Y
2⃣Part II: https://t.co/FrM9LpLVOf

[Pablo Cresta @pablo_cresta]

I am extremely happy to have been started my ESMO Research Fellowship and be part of these two great teams! Many thanks to @quimmateo and @rdienstmann, to @VHIO, and especially to @myESMO!!! 🤗🙌🏻

[Pablo Cresta @pablo_cresta]

@_lacion_ Thank you @_lacion_ !! You have been a cornerstone of my training during these last years. The support and confidence that you provide to your mentees are extremely powerful. It has been really inspiring working with you and @morlaicassiopea !! Thanks!!🤗

[Pablo Cresta @pablo_cresta]

@quimmateo @VHIO @myESMO many thanks to you @quimmateo, @rdienstmann, and the @vhio for this incredible oportunity!!! 🙌🏻

[ESMO - Eur. Oncology @myESMO]

1/ Congrats 🙌 to the 2021 ESMO Research #Fellowship Awardees: ambitious #cancerresearch projects kicking off soon👉👩‍🔬👨‍🔬 @pedrofsrocha @gaia_giannone @JcbenitezMD @CarausuMarcela @Pernelle_Lvd @pablo_cresta @TiagoCPadua
🔎Topics: https://t.co/ADrHQ7SlU7
@E_de_Azambuja #meded

[Pablo Cresta @pablo_cresta]

@_lacion_ Thank you for all the support and the learning opportunities!
These last 18 months with you and @morlaicassiopea have been extremely formatives! 🙌🏻

[Laura Ación (@[email protected]) @_lacion_]

✨Celebrating two pre-prints by @pablo_cresta, Martín Caruso, @morlaicassiopea:

👉🏽Practical Foundations of Machine Learning for Addiction Research

☝️🏽Part I. Methods and techniques: 10.31234/osf.io/ast53

✌️🏽Part II. Workflow and use cases: 10.31234/osf.io/6239v 🧵

[Pablo Cresta @pablo_cresta]

@HeidiBaya Great initiative!!!!
First episode: ✅
I will be tuned